Charles Kurkul, MD, is a board-certified hematologist and medical oncologist. He is an attending physician at Texas Oncology–Denton and cares for patients across affiliated community hospitals including Texas Health Presbyterian Hospital Denton and Medical City Denton. His clinical practice centers on gastrointestinal and hepato-pancreato-biliary oncology, breast oncology, and the full spectrum of benign and malignant hematology, with particular attention to complex coagulation management. Dr. Kurkul is a clinical investigator who serves as a principal investigator on local and national clinical trials. His research interests include novel anticancer therapeutics and trial development, anticoagulation pathways and supportive care optimization, and quality improvement to strengthen evidence-based care delivery in community settings. He is Chair and Program Director of the Ethics Committee at Texas Health Presbyterian Hospital Denton and is active in resident education and mentorship. His honors include Intern Teacher of the Year and a Veterans Affairs Medical Center Certificate of Recognition for clinical performance. Dr. Kurkul earned his MD from the University of Massachusetts Medical School, completed an internal medicine residency at Stony Brook Medicine, and completed fellowship training in hematology and oncology at the University of Massachusetts Medical School.
Attending Physician
Medical School
2006 – 2011
Residency
2011 – 2014
Fellowship
2014 – 2017